135 related articles for article (PubMed ID: 20008332)
1. Destruction of a destructor: a new avenue for cancer therapeutics targeting the Wnt pathway.
Liu C; He X
J Mol Cell Biol; 2010 Apr; 2(2):70-3. PubMed ID: 20008332
[TBL] [Abstract][Full Text] [Related]
2. PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.
Fearon ER
Cancer Cell; 2009 Nov; 16(5):366-8. PubMed ID: 19878868
[TBL] [Abstract][Full Text] [Related]
3. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-specific protease USP34 regulates axin stability and Wnt/β-catenin signaling.
Lui TT; Lacroix C; Ahmed SM; Goldenberg SJ; Leach CA; Daulat AM; Angers S
Mol Cell Biol; 2011 May; 31(10):2053-65. PubMed ID: 21383061
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery: Propping up a destructive regime.
Peterson RT
Nature; 2009 Oct; 461(7264):599-600. PubMed ID: 19794479
[No Abstract] [Full Text] [Related]
6. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
[TBL] [Abstract][Full Text] [Related]
7. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.
Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM
J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase is necessary for canonical Wnt signaling during kidney development.
Karner CM; Merkel CE; Dodge M; Ma Z; Lu J; Chen C; Lum L; Carroll TJ
Dev Dyn; 2010 Jul; 239(7):2014-23. PubMed ID: 20549720
[TBL] [Abstract][Full Text] [Related]
9. Wnt/Wingless Pathway Activation Is Promoted by a Critical Threshold of Axin Maintained by the Tumor Suppressor APC and the ADP-Ribose Polymerase Tankyrase.
Wang Z; Tacchelly-Benites O; Yang E; Thorne CA; Nojima H; Lee E; Ahmed Y
Genetics; 2016 May; 203(1):269-81. PubMed ID: 26975665
[TBL] [Abstract][Full Text] [Related]
10. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
Liu Z; Wang P; Wold EA; Song Q; Zhao C; Wang C; Zhou J
J Med Chem; 2021 Apr; 64(8):4257-4288. PubMed ID: 33822624
[TBL] [Abstract][Full Text] [Related]
11. WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling.
James RG; Davidson KC; Bosch KA; Biechele TL; Robin NC; Taylor RJ; Major MB; Camp ND; Fowler K; Martins TJ; Moon RT
PLoS One; 2012; 7(12):e50457. PubMed ID: 23227175
[TBL] [Abstract][Full Text] [Related]
12. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
[TBL] [Abstract][Full Text] [Related]
13. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta.
Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR
PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling.
Callow MG; Tran H; Phu L; Lau T; Lee J; Sandoval WN; Liu PS; Bheddah S; Tao J; Lill JR; Hongo JA; Davis D; Kirkpatrick DS; Polakis P; Costa M
PLoS One; 2011; 6(7):e22595. PubMed ID: 21799911
[TBL] [Abstract][Full Text] [Related]
15. Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions.
Jiang Y; Luo W; Howe PH
Oncogene; 2009 Aug; 28(33):2999-3007. PubMed ID: 19581931
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin conjugating enzyme E2 M promotes apoptosis in osteoarthritis chondrocytes via Wnt/β-catenin signaling.
Ba C; Ni X; Yu J; Zou G; Zhu H
Biochem Biophys Res Commun; 2020 Sep; 529(4):970-976. PubMed ID: 32819607
[TBL] [Abstract][Full Text] [Related]
17. Reconstituting regulation of the canonical Wnt pathway by engineering a minimal β-catenin destruction machine.
Pronobis MI; Deuitch N; Posham V; Mimori-Kiyosue Y; Peifer M
Mol Biol Cell; 2017 Jan; 28(1):41-53. PubMed ID: 27852897
[TBL] [Abstract][Full Text] [Related]
18. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
Chen B; Dodge ME; Tang W; Lu J; Ma Z; Fan CW; Wei S; Hao W; Kilgore J; Williams NS; Roth MG; Amatruda JF; Chen C; Lum L
Nat Chem Biol; 2009 Feb; 5(2):100-7. PubMed ID: 19125156
[TBL] [Abstract][Full Text] [Related]
19. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
Cselenyi CS; Jernigan KK; Tahinci E; Thorne CA; Lee LA; Lee E
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8032-7. PubMed ID: 18509060
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation.
Klement K; Brückner M; Bernkopf DB
J Cell Sci; 2023 Oct; 136(20):. PubMed ID: 37721093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
